Kate Dinneen
No ORCID on file
· 1 paper in corpus
review
2023
The use of molecular testing to direct diagnosis and treatment options in ovarian tumours has rapidly expanded in recent years, in particular with regard to the recommendation for routine homologous recombination deficiency (HRD) testing in…